Loading organizations...
Sensate develops a non-invasive wearable device and integrated application designed to promote stress reduction and enhance mental well-being. Its core technology utilizes patented infrasonic resonance to stimulate and tone the vagus nerve, which plays a crucial role in regulating the body's stress response. This approach aims to foster deep relaxation, improve sleep quality, and strengthen an individual's resilience to everyday stressors.
The company was founded by Stefan Chmelik, a recognized expert in Traditional Chinese Medicine and integrated health. With over three decades of professional experience in addressing issues related to stress and trauma, Chmelik’s insight led to the creation of a direct and accessible method for vagal nerve toning. He envisioned a technology that could deliver profound relaxation and nervous system regulation without extensive training or complex interventions.
Sensate primarily serves individuals seeking effective tools for managing anxiety, improving sleep patterns, and building greater emotional equilibrium. The company’s vision is to make significant physiological relaxation and nervous system balance readily available to a broad audience. It aims to empower users to proactively engage with their well-being, fostering a calmer, more resilient state through its innovative, science-backed solution.
Sensate has raised $3.0M across 1 funding round.
Sensate has raised $3.0M in total across 1 funding round.
Sensate has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in March 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 1, 2023 | $3M Seed | Incisive Ventures | Bloomberg Beta, Geek Ventures, Share Ventures, 37 Angels, Dangerous Ventures, Moai Capital, Unlock Venture Partners | Announced |
Sensate has raised $3.0M in total across 1 funding round.
Sensate's investors include Incisive Ventures, Bloomberg Beta, Geek Ventures, Share Ventures, 37 Angels, Dangerous Ventures, Moai Capital, Unlock Venture Partners.
Sensate is a wellness technology company that develops a wearable device for stress relief and relaxation, targeting the vagus nerve through infrasonic waves and bone conduction vibrations paired with a mobile app's soundscapes.[1][2][3][4] It serves individuals seeking non-invasive mental health support, solving problems like acute stress, anxiety, poor sleep, and low resilience by activating the parasympathetic nervous system in as little as 10 minutes without requiring meditation training.[1][2][4] The company, founded in 2016 and headquartered in Taunton, England, has raised $5.1M in seed VC funding, achieved 387% YoY revenue growth to $2.8M in 2021, and maintains strong customer ratings amid a booming mental health wearables market.[1][3]
Sensate was founded in 2016 by CEO Anna Gudmundson, a leader in integrated medicine, alongside co-founders who aimed to democratize vagus nerve stimulation for everyday stress management.[1][2][3] The idea emerged from Gudmundson's expertise in making profound relaxation accessible without years of training, leading to a patented device using sonic resonance on the sternum to calm the nervous system—opposite the fight-or-flight response.[3][4] Early traction built through venture backing from firms like Unlock Venture Partners and TenOneTen, culminating in a revenue surge from $583K in 2020 to $2.8M in 2021, plus crowdfunding on Wefunder at an $18M valuation.[1][3]
Sensate stands out in the mental health wearables space (ranked as a Challenger alongside Muse and Apollo) through these key advantages:
Sensate rides the explosive growth of mental health wearables, a market addressing rising demand for proactive tools tracking stress via sensors for heart rate variability, sleep, and anxiety amid global mental health crises.[1] Timing aligns with post-pandemic wellness booms, where consumers favor hardware-software combos over apps alone, fueled by remote work stress and aging populations seeking natural nervous system hacks.[1][3] Favorable forces include VC interest in biotech-wellness crossovers and regulatory tailwinds for non-pharma solutions; Sensate influences the ecosystem by pioneering consumer vagus nerve tech, challenging incumbents, and validating bone conduction for broader adoption in relaxation devices.[1][3][4]
Sensate is poised to scale beyond its $2.8M 2021 revenue through expanded distribution, app enhancements, and potential Series A funding, targeting mainstream wellness parity with firms like Headspace.[3] Trends like AI-personalized soundscapes, B2B enterprise wellness integrations, and hybrid vagus tech (e.g., with wearables like Apple Watch) will propel growth, especially as mental health spending surges.[1][3] Its influence could evolve from niche challenger to category leader, empowering accessible resilience in a high-stress world—echoing its founding mission to deliver meditation's benefits without the grind.[2][3][4]
